Monte Rosa Therapeutics, Inc. Insider Transactions
Purchase
Sell
Monte Rosa Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Leo Chandra P.
Director |
Buy | 10,000 @ $5.84 | $58,383 | 10,000 | 03/24/2025 | 03/25/2025 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 52,305 @ $9.08 | $475,008 | 1,589,053 | 10/29/2024 | 10/30/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 15,600 @ $9.41 | $146,793 | 1,573,453 | 10/29/2024 | 10/30/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 89,990 @ $9.66 | $869,240 | 2,007,948 | 10/28/2024 | 10/30/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 1,132,566 @ $6.53 | $7.40 M | 5,099,336 | 09/20/2024 | 09/24/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 9,269 @ $6.16 | $57,100 | 6,231,902 | 09/13/2024 | 09/13/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 16,047 @ $6.00 | $96,309 | 6,241,171 | 09/12/2024 | 09/13/2024 | |
|
Versant Venture Capital VI, L.P.
10 percent owner |
Sell | 541,897 @ $6.00 | $3.25 M | 6,257,218 | 09/11/2024 | 09/13/2024 | |
|
Dunn Edmund
Principal Accounting Officer |
Sell | 1,610 @ $3.83 | $6,166 | 13,944 | 07/05/2024 | 07/09/2024 | |
|
Dunn Edmund
Principal Accounting Officer |
Sell | 1,207 @ $4.04 | $4,876 | 15,554 | 06/03/2024 | 06/05/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Monte Rosa Therapeutics, Inc. FAQ's
The list of insiders at Monte Rosa Therapeutics, Inc. includes Dunn Edmund, Versant Venture Capital VI, L.P., Leo Chandra P..
Insiders have sold a total of 1.86 M Monte Rosa Therapeutics, Inc. shares in the last 12 months for a total of 12.30 M sold.
The following insiders have sold Monte Rosa Therapeutics, Inc. shares in the last 12 months: Dunn Edmund ($11,042), Versant Venture Capital VI, L.P. ($12.29 M),
Insiders have purchased a total of 10,000 Monte Rosa Therapeutics, Inc. shares in the last 12 months for a total of 58,383.
The following insiders have purchased Monte Rosa Therapeutics, Inc. shares in the last 12 months: Leo Chandra P. ($58,383),